Cargando…

Editorial: Metformin: Beyond Diabetes

Detalles Bibliográficos
Autores principales:	Bost, Frédéric, Rena, Graham, Viollet, Benoit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909380/ https://www.ncbi.nlm.nih.gov/pubmed/31866949 http://dx.doi.org/10.3389/fendo.2019.00851

Ejemplares similares

Editorial: Alternative Regenerative Medicine for Diabetes: Beyond the Stem Cell Approach
por: Peloso, Andrea
Publicado: (2021)

Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond
por: Tosti, Giulia, et al.
Publicado: (2023)

Editorial: Follicle-Stimulating Hormone: Fertility and Beyond
por: Simoni, Manuela, et al.
Publicado: (2019)

Metformin, an Anti-diabetic Drug to Target Leukemia
por: Biondani, Giulia, et al.
Publicado: (2018)

Editorial: AMPK and mTOR Beyond Signaling: Emerging Roles in Transcriptional Regulation
por: Audet-Walsh, Étienne, et al.
Publicado: (2021)

Editorial: Follicle-stimulating hormone: Fertility and beyond-volume II
por: Simoni, Manuela, et al.
Publicado: (2022)

Editorial: Bone marrow adiposity - contributions to bone, aging and beyond
por: Horton, Jason A., et al.
Publicado: (2023)

Editorial: Beyond Bariatric Surgery: Expected and Unexpected Long-Term Evolution
por: Schutz, Yves, et al.
Publicado: (2022)

GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
por: Ouyang, Jing, et al.
Publicado: (2020)

Metformin Use and Leukemia Risk in Patients With Type 2 Diabetes Mellitus
por: Tseng, Chin-Hsiao
Publicado: (2020)

Editorial: Association of novel anthropometric indexes with metabolic syndrome and beyond, volume II
por: Mohammadian Khonsari, Nami, et al.
Publicado: (2023)

Editorial: Inter-organ communication beyond mammals: the role of tissue-specific cytokines
por: Vélez, Emilio J., et al.
Publicado: (2023)

Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status
por: Cameron, Amy R., et al.
Publicado: (2016)

Editorial: Diabetes and aging
por: Barbosa, Helena Cristina de Lima
Publicado: (2022)

Editorial: Technologies for diabetes
por: Salzano, Giuseppina, et al.
Publicado: (2023)

Comparison of Clinical Efficacy and Safety of Metformin Sustained-Release Tablet (II) (Dulening) and Metformin Tablet (Glucophage) in Treatment of Type 2 Diabetes Mellitus
por: Guo, Li-xin, et al.
Publicado: (2021)

Metformin: update on mechanisms of action and repurposing potential
por: Foretz, Marc, et al.
Publicado: (2023)

Predictors for pharmacological therapy and perinatal outcomes with metformin treatment in women with gestational diabetes
por: Brzozowska, Malgorzata M., et al.
Publicado: (2023)

Metformin treatment and risk of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus in Beijing, China
por: Yang, Ruotong, et al.
Publicado: (2023)

Metformin: Focus on Melanoma
por: Jaune, Emilie, et al.
Publicado: (2018)

Metformin in Reproductive Biology
por: Faure, Melanie, et al.
Publicado: (2018)

Metformin and Colorectal Cancer
por: Higurashi, Takuma, et al.
Publicado: (2018)

Editorial: Cardiovascular Disease and Diabetes
por: Santulli, Gaetano
Publicado: (2019)

Editorial: Diabetes in the Middle East
por: Abu-Farha, Mohamed, et al.
Publicado: (2021)

Editorial: Covid-19 and Diabetes
por: Abu-Farha, Mohamed, et al.
Publicado: (2022)

The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review
por: Zangiabadian, Moein, et al.
Publicado: (2021)

Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes
por: Crouse, Andrew B., et al.
Publicado: (2021)

Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study
por: Tseng, Chin-Hsiao
Publicado: (2022)

Metformin therapy in pediatric type 2 diabetes mellitus and its comorbidities: A review
por: Alfaraidi, Haifa, et al.
Publicado: (2023)

Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes
por: Huang, Yuxin, et al.
Publicado: (2022)

Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023)

Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis
por: Forouzandeh, Farshad, et al.
Publicado: (2014)

Editorial: Sex and Gender Aspects in Diabetes
por: Kautzky-Willer, Alexandra, et al.
Publicado: (2019)

Editorial: Advanced Cardiovascular Imaging in Diabetes
por: Schick, Fritz, et al.
Publicado: (2022)

Editorial: Insights in exercise and diabetes management
por: Cyriac, T., et al.
Publicado: (2022)

Editorial: Advances in the research of diabetic retinopathy
por: Chakrabarti, Subrata, et al.
Publicado: (2022)

Editorial: Advances in the research of diabetic nephropathy
por: Abu-Farha, Mohamed, et al.
Publicado: (2023)

Editorial: Diabetic renal tubulointerstitial disease
por: Iizuka, Katsumi, et al.
Publicado: (2023)

Editorial: Emerging talents in clinical diabetes
por: Matafome, Paulo, et al.
Publicado: (2023)

Cost-Effectiveness of Dipeptidylpeptidase-4 Inhibitors Added to Metformin in Patients With Type 2 Diabetes in China
por: Lin, Wen-Qiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_biluj0ng8uqdl3b415q0amqq7l